Sarah Herburger

CA·SEDI

Supreme Pharmaceuticals Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (6 ops.)

€79k

Latest filing published 14 Oct 2016 for Supreme Pharmaceuticals Inc., €21k.

Insider track record

Disclosed buys

Disclosed sells

Signal history

Sarah Herburger: trading record in brief

Sarah Herburger is a declared insider of Supreme Pharmaceuticals Inc., with filings sourced from SEDI. Over a trading history stretching from 26 July 2016 to 11 October 2016, the count stands at 6 filings.

Every open-market trade on record is a sale: 6 sales worth €79k.

The newest entry dates from 14 October 2016: an open-market sale of €21k, in Supreme Pharmaceuticals Inc. The median gap between a trade and its publication by SEDI is 2 days. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEDI. Past trades are no guide to future returns.

Companies and markets linked to Sarah Herburger

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Supreme Pharmaceuticals Inc. (CA)

Declarations6 total

▼

Sarah Herburger

7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)Executives11 Oct 2016Supreme Pharmaceuticals Inc.

30,800 CAD14SEDI

20,000 shares@ CA$1.5426.6% of flowCommon SharesTSXSEDI:2902305

▼

Sarah Herburger

7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)Executives5 Oct 2016Supreme Pharmaceuticals Inc.

28,400 CAD13SEDI

20,000 shares@ CA$1.4224.3% of flowCommon SharesTSXSEDI:2900397

▼

Sarah Herburger

7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)Executives5 Oct 2016Supreme Pharmaceuticals Inc.

27,000 CAD13SEDI

20,000 shares@ CA$1.3523.1% of flowCommon SharesTSXSEDI:2900395

▼

Sarah Herburger

7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)Executives5 Oct 2016Supreme Pharmaceuticals Inc.

28,200 CAD13SEDI

20,000 shares@ CA$1.4124.1% of flowCommon SharesTSXSEDI:2900396

▼

Sarah Herburger

7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)Executives26 Jul 2016Supreme Pharmaceuticals Inc.

1,125 CAD11SEDI

2,500 shares@ CA$0.451.0% of flowCommon SharesTSXSEDI:2870933

▼

Sarah Herburger

7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)Executives27 Jul 2016Supreme Pharmaceuticals Inc.

1,125 CAD11SEDI

2,500 shares@ CA$0.451.0% of flowCommon SharesTSXSEDI:2870935

6 of 6 declarations

Sarah Herburger: trading record in brief

Every open-market trade on record is a sale: 6 sales worth €79k.

Sarah Herburger

Insider track record

Sarah Herburger: trading record in brief

Companies and markets linked to Sarah Herburger

Related entities

Sarah Herburger

Insider track record

Sarah Herburger: trading record in brief

Companies and markets linked to Sarah Herburger

Related entities